Original Articles: Bladder Cancer: Keyhole-Limpet Hemocyanin Immunotherapy in the Bilharzial Bladder: A New Treatment Modality? Phase II Trial: Superficial Bladder Cancer

Mohamed M. Wishahi; Ismail M.H. Ismail; Herbert Ruebben; Thomas. Otto

doi:10.1016/s0022-5347(01)67605-5

Original Articles: Bladder Cancer: Keyhole-Limpet Hemocyanin Immunotherapy in the Bilharzial Bladder: A New Treatment Modality? Phase II Trial: Superficial Bladder Cancer

The Journal of Urology ◽

10.1016/s0022-5347(01)67605-5 ◽

1995 ◽

Vol 153 (3S) ◽

pp. 926-928 ◽

Cited By ~ 8

Author(s):

Mohamed M. Wishahi ◽

Ismail M.H. Ismail ◽

Herbert Ruebben ◽

Thomas. Otto

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Treatment Modality ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Keyhole Limpet Hemocyanin ◽

New Treatment

Download Full-text

Evaluation of an Unconventional Treatment Modality with Mistletoe Lectin to Prevent Recurrence of Superficial Bladder Cancer: A Randomized Phase ii Trial

The Journal of Urology ◽

10.1016/s0022-5347(05)64834-3 ◽

2002 ◽

Vol 168 (1) ◽

pp. 72-75 ◽

Cited By ~ 24

Author(s):

Peter J. Goebell ◽

Thomas Otto ◽

Julia Suhr ◽

Herbert Rübben

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Treatment Modality ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Mistletoe Lectin ◽

Randomized Phase Ii

Download Full-text

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2005.11.026 ◽

2006 ◽

Vol 24 (4) ◽

pp. 344-348 ◽

Cited By ~ 158

Author(s):

Fadi N. Joudi ◽

Brian J. Smith ◽

Michael A. O’Donnell

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Interferon Α ◽

Bacillus Calmette Guerin ◽

Multicenter Phase

Download Full-text

Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2005.03.010 ◽

2005 ◽

Vol 23 (3) ◽

pp. 218

Author(s):

William A. See

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Interferon Alfa ◽

Bacillus Calmette Guerin ◽

Multicenter Phase

Download Full-text

Preliminary results of phase II trial of concomitant administration of intra-vesical reduced dose Bacillus Calmette- Guerin (BCG) and interferon a 2B (IFN) in the prevention of recurrence of superficial bladder cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4716 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4716-4716

Author(s):

S. Bazarbashi ◽

M. Raja ◽

S. Kattan ◽

M. Rahal ◽

A. El-Weshi ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Concomitant Administration ◽

Bacillus Calmette Guerin ◽

Preliminary Results ◽

Reduced Dose ◽

Prevention Of Recurrence

Download Full-text

Preliminary results of phase II trial of concomitant administration of intra-vesical reduced dose Bacillus Calmette- Guerin (BCG) and interferon a 2B (IFN) in the prevention of recurrence of superficial bladder cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4716 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4716-4716

Author(s):

S. Bazarbashi ◽

M. Raja ◽

S. Kattan ◽

M. Rahal ◽

A. El-Weshi ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Concomitant Administration ◽

Bacillus Calmette Guerin ◽

Preliminary Results ◽

Reduced Dose ◽

Prevention Of Recurrence

Download Full-text

INTERIM RESULTS FROM A NATIONAL MULTICENTER PHASE II TRIAL OF COMBINATION BACILLUS CALMETTE-GUERIN PLUS INTERFERON ALFA-2B FOR SUPERFICIAL BLADDER CANCER

The Journal of Urology ◽

10.1097/01.ju.0000136446.37840.0a ◽

2004 ◽

Vol 172 (3) ◽

pp. 888-893 ◽

Cited By ~ 69

Author(s):

MICHAEL A. O’DONNELL ◽

KATHLEEN LILLI ◽

CHRISTINA LEOPOLD ◽

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Interferon Alfa ◽

Bacillus Calmette Guerin ◽

Multicenter Phase

Download Full-text

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer

Yearbook of Urology ◽

10.1016/s0084-4071(08)70108-8 ◽

2007 ◽

Vol 2007 ◽

pp. 137-138

Author(s):

A.S. Kibel

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Interferon Α ◽

Bacillus Calmette Guerin ◽

Multicenter Phase

Download Full-text

203 PRELIMINARY RESULTS OF A PHASE II TRIAL OF IRINOTECAN (I) AND GEMCITABINE (G) IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BLADDER CANCER.

Journal of Investigative Medicine ◽

10.1136/jim-52-suppl1-756 ◽

2004 ◽

Vol 52 (Suppl 1) ◽

pp. S293.3-S293

Author(s):

U B Chaudhary ◽

S Shannon ◽

N Curry ◽

T E Keane ◽

R T Means

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Preliminary Results ◽

Metastatic Bladder Cancer

Download Full-text

Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer

European Urology ◽

10.1016/j.eururo.2019.07.019 ◽

2019 ◽

Vol 76 (6) ◽

pp. 870-871

Author(s):

Charlotte S. Voskuilen ◽

Michiel S. van der Heijden ◽

Bas W.G. van Rhijn

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Prospective Phase ◽

Muscle Invasive ◽

Dose Dense

Download Full-text

Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response

The Journal of Urology ◽

10.1016/j.juro.2006.06.007 ◽

2006 ◽

Vol 176 (4) ◽

pp. 1349-1353 ◽

Cited By ~ 53

Author(s):

Antoine G. van der Heijden ◽

Paula M.J. Moonen ◽

Erik B. Cornel ◽

Henk Vergunst ◽

Theo M. de Reijke ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Superficial Bladder Cancer ◽

Intravesical Instillation

Download Full-text